A Pilot Pharmacokinetic and Antiangiogenic Biomarker Study of Celecoxib and Low-dose Metronomic Vinblastine or Cyclophosphamide in Pediatric Recurrent Solid Tumors-Reference-Cited by-同舟云学术

A Pilot Pharmacokinetic and Antiangiogenic Biomarker Study of Celecoxib and Low-dose Metronomic Vinblastine or Cyclophosphamide in Pediatric Recurrent Solid Tumors

Published:2006-11 Issue:11 Volume:28 Page:720-728
ISSN:1077-4114
Container-title:Journal of Pediatric Hematology/Oncology
language:en
Short-container-title:

Author:

Stempak Diana,Gammon Janet,Halton Jacqueline,Moghrabi Albert,Koren Gideon,Baruchel Sylvain

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference31 articles.

1. What is the evidence that tumors are angiogenesis dependent?;Folkman;J Natl Cancer Inst,1990

2. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer;Browder;Cancer Res,2000

3. Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity;Klement;J Clin Invest,2000

4. A multitargeted, metronomic, and maximum-tolerated dose “chemo-switch” regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer;Pietras;J Clin Oncol,2005

5. The anti-angiogenic basis of metronomic chemotherapy;Kerbel;Nat Rev Cancer,2004

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution and contemporary role of metronomic chemotherapy in the treatment of neuroblastoma;Cancer Letters;2024-04

2. Personalized treatment options of refractory and relapsed medulloblastoma in children: literature review;Journal of Modern Oncology;2024-02-21

3. Continuous low-dose cyclophosphamide plus prednisone in the treatment of relapsed and refractory multiple myeloma with severe complications;Frontiers in Oncology;2023-05-22

4. Oral vinorelbine and continuous low doses of cyclophosphamide in pediatric rhabdomyosarcoma: a real-world study;Frontiers in Pharmacology;2023-05-03

5. Effectiveness of metronomic chemotherapy in a child with medulloblastoma: A case report;Oncology Letters;2023-03-30